The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Crohn’s Disease Diagnostic and Therapeutic-Global Market Insights and Sales Trends 2024
Synopsis
Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from mouth to the anus. It is caused by a combination of environmental, immune, and bacterial factors, in genetically predisposed individuals.
The global Crohn’s Disease Diagnostic and Therapeutic market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Crohn’s Disease Diagnostic and Therapeutic in various end use industries. The expanding demands from the Hospital, Medical Research Institute and Other,, are propelling Crohn’s Disease Diagnostic and Therapeutic market. Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Treatment segment is estimated at % CAGR for the next seven-year period.
This market is closely related to the pharmaceutical market.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Crohn’s Disease Diagnostic and Therapeutic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Crohn’s Disease Diagnostic and Therapeutic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Crohn’s Disease Diagnostic and Therapeutic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Crohn’s Disease Diagnostic and Therapeutic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Crohn’s Disease Diagnostic and Therapeutic covered in this report include Abbvie, Celgene, Genetech, Johnson & Johnson, Pfizer, Prometheus Laboratories, Salix Pharmaceuticals and Takeda Pharmaceutical, etc.
The global Crohn’s Disease Diagnostic and Therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbvie
Celgene
Genetech
Johnson & Johnson
Pfizer
Prometheus Laboratories
Salix Pharmaceuticals
Takeda Pharmaceutical
Global Crohn’s Disease Diagnostic and Therapeutic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Crohn’s Disease Diagnostic and Therapeutic market, Segment by Type:
Diagnostics
Treatment
Global Crohn’s Disease Diagnostic and Therapeutic market, by Application
Hospital
Medical Research Institute
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Crohn’s Disease Diagnostic and Therapeutic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from mouth to the anus. It is caused by a combination of environmental, immune, and bacterial factors, in genetically predisposed individuals.
The global Crohn’s Disease Diagnostic and Therapeutic market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Crohn’s Disease Diagnostic and Therapeutic in various end use industries. The expanding demands from the Hospital, Medical Research Institute and Other,, are propelling Crohn’s Disease Diagnostic and Therapeutic market. Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Treatment segment is estimated at % CAGR for the next seven-year period.
This market is closely related to the pharmaceutical market.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Crohn’s Disease Diagnostic and Therapeutic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Crohn’s Disease Diagnostic and Therapeutic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Crohn’s Disease Diagnostic and Therapeutic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Crohn’s Disease Diagnostic and Therapeutic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Crohn’s Disease Diagnostic and Therapeutic covered in this report include Abbvie, Celgene, Genetech, Johnson & Johnson, Pfizer, Prometheus Laboratories, Salix Pharmaceuticals and Takeda Pharmaceutical, etc.
The global Crohn’s Disease Diagnostic and Therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbvie
Celgene
Genetech
Johnson & Johnson
Pfizer
Prometheus Laboratories
Salix Pharmaceuticals
Takeda Pharmaceutical
Global Crohn’s Disease Diagnostic and Therapeutic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Crohn’s Disease Diagnostic and Therapeutic market, Segment by Type:
Diagnostics
Treatment
Global Crohn’s Disease Diagnostic and Therapeutic market, by Application
Hospital
Medical Research Institute
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Crohn’s Disease Diagnostic and Therapeutic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Crohn’s Disease Diagnostic and Therapeutic
1.1 Crohn’s Disease Diagnostic and Therapeutic Market Overview
1.1.1 Crohn’s Disease Diagnostic and Therapeutic Product Scope
1.1.2 Crohn’s Disease Diagnostic and Therapeutic Market Status and Outlook
1.2 Global Crohn’s Disease Diagnostic and Therapeutic Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2018-2029)
1.4 Global Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Region (2018-2023)
1.5 Global Crohn’s Disease Diagnostic and Therapeutic Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Crohn’s Disease Diagnostic and Therapeutic Market Size (2018-2029)
1.6.1 North America Crohn’s Disease Diagnostic and Therapeutic Market Size (2018-2029)
1.6.2 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size (2018-2029)
1.6.3 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size (2018-2029)
1.6.4 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size (2018-2029)
1.6.5 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size (2018-2029)
2 Crohn’s Disease Diagnostic and Therapeutic Market by Type
2.1 Introduction
2.1.1 Diagnostics
2.1.2 Treatment
2.2 Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Type (2018-2023)
2.2.2 Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Crohn’s Disease Diagnostic and Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Crohn’s Disease Diagnostic and Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Crohn’s Disease Diagnostic and Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Crohn’s Disease Diagnostic and Therapeutic Revenue Breakdown by Type (2018-2029)
3 Crohn’s Disease Diagnostic and Therapeutic Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Medical Research Institute
3.1.3 Other
3.2 Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Application (2018-2023)
3.2.2 Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Crohn’s Disease Diagnostic and Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Crohn’s Disease Diagnostic and Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Crohn’s Disease Diagnostic and Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Crohn’s Disease Diagnostic and Therapeutic Revenue Breakdown by Application (2018-2029)
4 Crohn’s Disease Diagnostic and Therapeutic Competition Analysis by Players
4.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Crohn’s Disease Diagnostic and Therapeutic as of 2022)
4.3 Date of Key Players Enter into Crohn’s Disease Diagnostic and Therapeutic Market
4.4 Global Top Players Crohn’s Disease Diagnostic and Therapeutic Headquarters and Area Served
4.5 Key Players Crohn’s Disease Diagnostic and Therapeutic Product Solution and Service
4.6 Competitive Status
4.6.1 Crohn’s Disease Diagnostic and Therapeutic Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbvie
5.1.1 Abbvie Profile
5.1.2 Abbvie Main Business
5.1.3 Abbvie Crohn’s Disease Diagnostic and Therapeutic Products, Services and Solutions
5.1.4 Abbvie Crohn’s Disease Diagnostic and Therapeutic Revenue (US$ Million) & (2018-2023)
5.1.5 Abbvie Recent Developments
5.2 Celgene
5.2.1 Celgene Profile
5.2.2 Celgene Main Business
5.2.3 Celgene Crohn’s Disease Diagnostic and Therapeutic Products, Services and Solutions
5.2.4 Celgene Crohn’s Disease Diagnostic and Therapeutic Revenue (US$ Million) & (2018-2023)
5.2.5 Celgene Recent Developments
5.3 Genetech
5.3.1 Genetech Profile
5.3.2 Genetech Main Business
5.3.3 Genetech Crohn’s Disease Diagnostic and Therapeutic Products, Services and Solutions
5.3.4 Genetech Crohn’s Disease Diagnostic and Therapeutic Revenue (US$ Million) & (2018-2023)
5.3.5 Johnson & Johnson Recent Developments
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Profile
5.4.2 Johnson & Johnson Main Business
5.4.3 Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Products, Services and Solutions
5.4.4 Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Revenue (US$ Million) & (2018-2023)
5.4.5 Johnson & Johnson Recent Developments
5.5 Pfizer
5.5.1 Pfizer Profile
5.5.2 Pfizer Main Business
5.5.3 Pfizer Crohn’s Disease Diagnostic and Therapeutic Products, Services and Solutions
5.5.4 Pfizer Crohn’s Disease Diagnostic and Therapeutic Revenue (US$ Million) & (2018-2023)
5.5.5 Pfizer Recent Developments
5.6 Prometheus Laboratories
5.6.1 Prometheus Laboratories Profile
5.6.2 Prometheus Laboratories Main Business
5.6.3 Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Products, Services and Solutions
5.6.4 Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Revenue (US$ Million) & (2018-2023)
5.6.5 Prometheus Laboratories Recent Developments
5.7 Salix Pharmaceuticals
5.7.1 Salix Pharmaceuticals Profile
5.7.2 Salix Pharmaceuticals Main Business
5.7.3 Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Products, Services and Solutions
5.7.4 Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Revenue (US$ Million) & (2018-2023)
5.7.5 Salix Pharmaceuticals Recent Developments
5.8 Takeda Pharmaceutical
5.8.1 Takeda Pharmaceutical Profile
5.8.2 Takeda Pharmaceutical Main Business
5.8.3 Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Products, Services and Solutions
5.8.4 Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Revenue (US$ Million) & (2018-2023)
5.8.5 Takeda Pharmaceutical Recent Developments
6 North America
6.1 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Crohn’s Disease Diagnostic and Therapeutic Market Dynamics
11.1 Crohn’s Disease Diagnostic and Therapeutic Industry Trends
11.2 Crohn’s Disease Diagnostic and Therapeutic Market Drivers
11.3 Crohn’s Disease Diagnostic and Therapeutic Market Challenges
11.4 Crohn’s Disease Diagnostic and Therapeutic Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
